Altered phosphorylation state of branched‐chain 2‐Oxo acid dehydrogenase in a branched‐chain acyltransferase deficient human fibroblast cell line

Abstract
The abundance and phosphorylation state of the polypeptide constitutents of the human branched-chain 2-oxo acid dehydrogenase complex were examined in mitochondria from normal and maple syrup urine disease (MSUD) fibroblasts. In normal fibroblast mitochondria two forms of the E subunit were observed: non-phosphorylated (E) and phosphorylated (E1α−P). About 40–50% of E was present as E1α−P. The ability to quantitate the two forms of E permitted examination of the association between decreased capacity to oxidize branched-chain 2-oxo acids and the phosphorylation state of E. Changes in phosphorylation state of E were observed in MSUD fibroblasts as compared to control cells. Of particular interest was the absence of E1α−P in an MSUD fibroblast line which lacked the dihydrolipoyl acyltransferase (E2) subunit of the dehydrogenase complex. In two MSUD cell lines deficient in E, the abundance of E1α−P appeared to be preferentially reduced. A fourth MSUD cell line contained normal quantities of E3, E2 and both forms of the E polypeptide. Our results indicate that alterations in the abundance of dehydrogenase complex polypeptides in MSUD fibroblasts may influence the phosphorylation state of the E polypeptide. They demonstrate the potential for examining simultaneously mutations which affect both the catalytic and regulatory components of the dehydrogenase complex.

This publication has 26 references indexed in Scilit: